| Literature DB >> 27930479 |
Salla Toppinen-Tanner1, Petri Böckerman, Pertti Mutanen, Kari-Pekka Martimo, Jukka Vuori.
Abstract
This study examined whether a group intervention focusing on building up preparedness for career management can prevent future sickness absence.Register-based data on the number of sickness absence days and sickness absence episodes were examined as outcomes of the intervention among 684 employees in 17 organizations in a randomized controlled trial. Sickness absence data were collected covering a period from 1 year before (baseline) to approximately 2 years after the intervention (follow-up). The data were analyzed using zero-inflated negative binomial models.After controlling for baseline absence, age, gender, and organization, the intervention was effective in decreasing the number of longer sickness absences (lasting longer than > 2 weeks), but no other significant effects were found.These findings point out that it is feasible to use a career management intervention to prevent future sickness absence in work organizations.Entities:
Mesh:
Year: 2016 PMID: 27930479 PMCID: PMC5172807 DOI: 10.1097/JOM.0000000000000887
Source DB: PubMed Journal: J Occup Environ Med ISSN: 1076-2752 Impact factor: 2.162
FIGURE 1Flow chart of study design and study participants (T2 refers to respondents to time 2 measurement of proximal effects).
Characteristics of Study Population by Intervention Group at the Baseline and During Follow-Up
| All ( | Intervention Group ( | Control Group ( | Difference Between the Groups ( | Sum of Absences Per Year in Intervention/Control Group | |
| Demographic variables ( | |||||
| Sex | Chi-square | ||||
| Men | 85 (12%) | 50 (14%) | 35 (10%) | ||
| Women | 599 (88%) | 300 (86%) | 299 (90%) | ||
| Age | 50.02 (6.53) | 50.44 (6.57) | 49.58 (6.46) | −1.58, | |
| Baseline sickness absence; Mean per person/year (SD) | |||||
| Sickness absence days | 11.85 (27.88) | 10.93 (28.50) | 12.81 (27.23) | 0.89, | 3,876/4,270 |
| Sickness absence episodes | 1.75 (2.13) | 1.62 (1.92) | 1.88 (2.32) | 1.60, | 580/622 |
| Short episodes (<4 days) | 1.20 (1.57) | 1.12 (1.46) | 1.29 (1.67) | 1.47, | 398/427 |
| Long episodes (≥4 days) | 0.54 (1.00) | 0.50 (0.89) | 0.58 (1.11) | 1.10, | 182/195 |
| Longer episodes (>14 days) | 0.14 (0.39) | 0.12 (0.35) | 0.16 (0.42) | 1.11, | 43/52 |
| Sickness absence during follow-up; Mean per person/year (SD) | |||||
| Sickness absence days | 13.61 (29.23) | 12.22 (24.12) | 15.07 (33.74) | 1.56, | 4,288/5,020 |
| Sickness absence episodes | 1.82 (2.10) | 1.76 (1.94) | 1.90 (2.26) | 1.27, | 619/627 |
| Short episodes (<4 days) | 1.26 (1.58) | 1.22 (1.45) | 1.31 (1.70) | 1.22, | 430/433 |
| Long episodes (≥4 days) | 0.56 (0.83) | 0.58 (0.86) | 0.54 (0.80) | 1.01, | 189/194 |
| Longer episodes (>14 days) | 0.16 (0.33) | 0.15 (0.30) | 0.17 (0.37) | 0.58, | 52/55 |
Main Effects of the Intervention on Sickness Absence Days and Episodes
| Model 0 | Model 1 | Model 2 | ||||
| Model | OR (95% CI) | OR (95% CI) | OR (95% CI) | |||
| Sickness absence days | 0.82 (0.62–1.08) | 0.158 | 0.78 (0.61–1.00) | 0.054 | 0.86 (0.68–1.09) | 0.208 |
| Sickness absence episodes (all) | 0.92 (0.78–1.11) | 0.416 | 0.92 (0.79–1.07) | 0.291 | 1.06 (0.94–1.21) | 0.324 |
| Short episodes (<4 days) | 0.92 (0.76–1.12) | 0.404 | 0.95 (0.81–1.11) | 0.529 | 1.07 (0.93–1.23) | 0.363 |
| Long episodes (≥4 days) | 0.87 (0.66–1.14) | 0.322 | 0.80 (0.65–1.00) | 0.050 | 0.88 (0.72–1.07) | 0.206 |
| Longer episodes (>14 days) | 0.65 (0.42–1.00) | 0.048 | 0.51 (0.34–0.78) | 0.001 | 0.53 (0.35–0.82) | 0.004 |
Model 0. Crude.
Model 1. Adjusted for age, gender, and organization.
Model 2. Adjusted for age, gender, organization, and previous absence.
Models adjusted for previous absence, age, gender, and organization (ZINB models).
95% CI, 95% confidence interval; OR, odds ratio.